
Sign up to save your podcasts
Or


Beverly Tchang MD of Weill Cornell Medicine shares perspectives on today’s obesity trends, and touches on emerging innovative approaches from Noom, Weight Watchers, MyFitnessPal, LoseIt, as well as new medications such as Semaglutide (AKA Wegovy by Novo Nordisk).
By Paul Schrimpf5
1616 ratings
Beverly Tchang MD of Weill Cornell Medicine shares perspectives on today’s obesity trends, and touches on emerging innovative approaches from Noom, Weight Watchers, MyFitnessPal, LoseIt, as well as new medications such as Semaglutide (AKA Wegovy by Novo Nordisk).